http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112294957-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b54b26a418326924737f4f78ca42feb1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2020-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28f7927ebc6bc3d035af7558f0c6801c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_317869b6de0c485a67bc06fd095fd486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d70012ec235b78823124628d2d0313d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cd5b97321cc15f3a3675e8a427a4db5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2e6ac7f45a0ad92a66756d94c2560f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d97e456785768aa05645f59675581a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0b2aa287b5dfeb5e46b406cd1fc78e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0721305207391a99edd60eb43b63d455
publicationDate 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112294957-A
titleOfInvention Application of human melanoma-related circular RNA circROR1 targets in the preparation of melanoma drugs
abstract The invention relates to the technical field of biomedicine, and discloses an application of a human melanoma-related circular RNA circROR1 target in preparing a melanoma drug. The present invention shows that human melanoma-related circular RNA circROR1 and binding protein PTBP1 have potential roles in melanoma drug treatment, melanoma prognosis evaluation, and melanoma curative effect monitoring, and the present invention provides more intensive clinical treatment of melanoma. Alternatively, the drugs of the present invention and related mechanisms of action may be novel strategies for improving melanoma treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114015693-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114015693-B
priorityDate 2020-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID340273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7393
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8628745
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID323490
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID420098
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42620
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25630
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29497
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547014
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID512571
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9999
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID485097
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32108
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18746
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396456
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9WUM7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100008676
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537854
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5315
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID798527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45343
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID826974

Total number of triples: 52.